
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Shares | 100.00 | 100.00 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 25.57 | 24.02 |
Price to Book | 8.81 | 4.87 |
Price to Sales | 5.37 | 3.66 |
Price to Cash Flow | 19.56 | 16.71 |
Dividend Yield | 1.59 | 1.22 |
5 Years Earnings Growth | 11.15 | 12.24 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 26.93 | 14.56 |
Consumer Defensive | 23.87 | 6.25 |
Technology | 20.80 | 28.78 |
Communication Services | 12.08 | 9.21 |
Consumer Cyclical | 8.98 | 12.66 |
Financial Services | 4.62 | 14.24 |
Industrials | 2.73 | 11.95 |
Number of long holdings: 28
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Microsoft | US5949181045 | 9.07 | 393.31 | -0.90% | |
Meta Platforms | US30303M1027 | 8.68 | 625.66 | -0.36% | |
Novo Nordisk B | DK0062498333 | 8.07 | 597.6 | -2.42% | |
L'Oreal | FR0000120321 | 6.23 | 359.55 | -1.71% | |
Stryker | US8636671013 | 5.80 | 379.30 | -0.79% | |
Visa A | US92826C8394 | 4.62 | 345.32 | +0.34% | |
ADP | US0530151036 | 4.55 | 306.45 | +1.32% | |
Philip Morris | US7181721090 | 4.54 | 150.95 | -1.69% | |
IDEXX Labs | US45168D1046 | 4.14 | 430.12 | +0.25% | |
Louis Vuitton | FR0000121014 | 3.99 | 634.70 | -2.80% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fundsmith Equity I Acc | 13.51B | 3.88 | 8.17 | 13.49 | ||
Fundsmith Equity R Acc | 582.04M | 3.78 | 7.52 | 12.80 | ||
Fundsmith Equity R Inc | 15.58M | 3.78 | 7.52 | 12.80 | ||
Fundsmith Equity T Acc | 3.86B | 3.87 | 8.06 | 13.37 | ||
Fundsmith Equity T Inc | 231.52M | 3.75 | 8.06 | 13.37 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review